Results 121 to 130 of about 1,790 (131)

Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma. [PDF]

Commun Med (Lond)
Tougeron D, Louvet C, Desramé J, Evesque L, Angelergues A, Carnot A, Breysacher G, Zaanan A, Etchepare N, Mabro M, Kaluzinski L, Petorin C, Chibaudel B, Aparicio T, Bodere A, Rinaldi Y, Le Malicot K, Emile JF, Lepage C, Baures A, Djamai H, Taly V, Laurent-Puig P.   +22 more
europepmc   +1 more source

Direct metagenomic and amplicon-based Nanopore sequencing of French human monkeypox from clinical specimen. [PDF]

Microbiol Resour Announc
Kwasiborski A, Hourdel V, Balière C, Hoinard D, Grassin Q, Feher M, De La Porte Des Vaux C, Cresta M, Vanhomwegen J, Manuguerra J-C, Batéjat C, Caro V.   +11 more
europepmc   +1 more source

Thermodynamic performance of organic rankine cycle based pumped thermal energy storage system with different working fluids. [PDF]

Heliyon
Liang Z, Zheng G, Wu G, Pan Z, Hu Z, Xu M, Chen H.   +6 more
europepmc   +1 more source

Fundamental Limits of an Irreversible Heat Engine. [PDF]

Entropy (Basel)
Fu R.
europepmc   +1 more source

Complete DPYD genotyping combined with dihydropyrimidine dehydrogenase phenotyping to prevent fluoropyrimidine toxicity: A retrospective study. [PDF]

Cancer Med
De Metz C, Hennart B, Aymes E, Cren PY, Martignène N, Penel N, Barthoulot M, Carnot A.   +7 more
europepmc   +1 more source

A scalable and eco-friendly carbohydrate-based oleogelator for vitamin E controlled delivery. [PDF]

RSC Adv
Fragal EH, Metilli L, Pignon F, Halila S.   +3 more
europepmc   +1 more source

Isolation and Characterization of Cellulose Nanocrystals from Bacterial Cellulose Synthesized via <i>Ancylobacter</i> sp. STN1A Using Residual Glycerol. [PDF]

Polymers (Basel)
Peña-Ortiz M, García A, Martirani-Von Abercron SM, Marín P, Marqués S, Khiari R, Dufresne A, Serrano L.   +7 more
europepmc   +1 more source

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial. [PDF]

J Immunother Cancer
Blanc J, Carnot A, Barthélémy P, Casert V, Sautois B, Van den Brande J, Vanhaudenarde V, Staudacher L, Seront E, Debien V, Ameye L, Kotecki N, Rothé F, Rorive S, Fantoni JC, Tricard T, Roumeguère T, Awada A, Martinez Chanza N.   +18 more
europepmc   +1 more source